USPTO 2015–2025 USPTO PatentsView Foreign Corporation

National Health Research Institutes

USPTO PatentsView assignee record - 84 granted patents across 34 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

14.3

Avg claims per patent

+15%

5-year filing velocity

The verdict

National holds 84 US patents across 34 technology areas, rank #4,251 of 50,000 tracked assignees.

#4,251
of 50,000 US assignees by volume: Top 12%
by Innovation Score (51.2/100): 14.3
avg claims per patent: +15%
filing velocity, last 5 yrs

Portfolio overview

National Health Research Institutes has been granted 84 US utility patents between 2015 and 2025, placing National Health Research Institutes at rank #4,251 across all assignees tracked by PlainPatent. This portfolio spans 34 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.3 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, National Health Research Institutes is one of the more focused assignees in the PatentsView dataset. By volume, National sits between Jtekt Europe (84 patents, rank #4,247) and Prince Castle Llc (84 patents, rank #4,255) - the closest US assignees by grant volume. The composite Innovation Score of 51.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 45 grants, compared with 39 in the 2015–2019 window, a +15% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. National Health Research Institutes's 14.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 34 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark National Health Research Institutes against peers pursuing similar technology classes.

Jtekt Europe

84
Kitagawa Industri…

84
M Technique

84
Mallinckrodt Hosp…

84
Nisca

84
Optis Cellular Te…

84
Orthosensor

84
Prince Castle

84
National Health R… ◀

84

What this shows National holds 84 patents at rank #4,251, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near National

By rank, the assignees closest to #4,251 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in National's primary technology class.

National's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

National Health Research Institutes patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	11	13.1%
2016	9	10.7%
2017	4	4.8%
2018	7	8.3%
2019	8	9.5%
2020	8	9.5%
2021	7	8.3%
2022	8	9.5%
2023	7	8.3%
2024	8	9.5%
2025	7	8.3%

Which technologies does National Health Research Institutes patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 57

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 50

C07D - HETEROCYCLIC COMPOUNDS 24

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 22

C07K - PEPTIDES 20

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 13

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 7

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 6

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 6

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 4

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 4

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 3

C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM 3

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 2

Top 15 of 34 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#4,251

Across all tracked assignees

Innovation Score

51.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does National Health Research Institutes hold?

National Health Research Institutes holds 84 US granted patents filed between 2015 and 2025, spanning 34 technology areas.

What is National Health Research Institutes's Innovation Score?

National Health Research Institutes has an Innovation Score of 51.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does National Health Research Institutes focus on?

National Health Research Institutes's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 57 patents. The company has filed patents in 34 CPC subclasses total.

Is National Health Research Institutes's patent filing rate increasing or decreasing?

National Health Research Institutes's recent filing velocity is +15% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for National Health Research Institutes's patents?

National Health Research Institutes's patents average 14.3 claims each. This falls within the standard range, providing solid legal coverage.

How is the National Health Research Institutes patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

National's 84 grants land it in the top 12% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - National ranks #4,251 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.